Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-d-glucose: Healthy aging Alzheimer's disease and down syndrome
- 1 January 1986
- journal article
- review article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 10 (3-5) , 309-321
- https://doi.org/10.1016/0278-5846(86)90010-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Brain metabolism as measured with positron emission tomographyNeurology, 1985
- Clinical history, brain metabolism, and neuropsychological function in Alzheimer's diseaseAnnals of Neurology, 1985
- Human brain glucose utilization and cognitive function in relation to ageAnnals of Neurology, 1984
- BRAIN METABOLISM AS MEASURED WITH POSITRON EMISSION TOMOGRAPHYClinical Neuropharmacology, 1984
- CEREBRAL GLUCOSE UTILIZATION, AS MEASURED WITH POSITRON EMISSION TOMOGRAPHY IN 21 RESTING HEALTHY MEN BETWEEN THE AGES OF 21 AND 83 YEARSBrain, 1983
- Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological gradingHistopathology, 1981
- Quantitative evidence for selective dendritic growth in normal human aging but not in senile dementiaBrain Research, 1981
- Quantitative Measurement of Regional Cerebral Blood Flow and Oxygen Metabolism in Man Using 15O and Positron Emission TomographyJournal of Computer Assisted Tomography, 1980
- “Mini-mental state”Journal of Psychiatric Research, 1975
- The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly SubjectsThe British Journal of Psychiatry, 1968